Subnavigation

• Tuberculosis
• TB Topics index
• Stop TB Strategy
• DOTS expansion
• TB diagnostics and laboratories
• TB/HIV
  MDR/XDR-TB
• Health systems
• Public-Private Mix
• Community engagement
• TB research
• TB data
• TB publications
• About us

Global Task Force on TB Impact Measurement

Documents produced by the Task Force (in chronological order)

Tuberculosis prevalence surveys: an educational series. Int J Tuberc Lung Dis.

• Tuberculosis prevalence surveys: an educational series. (Editorial) Glaziou P. Int J Tuberc Lung Dis. 2008 Sep;12(9):985.
• Tuberculosis prevalence surveys: rationale and cost. (No. 1 in the Educational series) Glaziou P, van der Werf MJ, Onozaki I, Dye C, Borgdorff MW, Chiang CY, Cobelens F, Enarson DA, Gopi PG, Holtz TH, Kim SJ, van Leth F, Lew WJ, Lonnroth K, van Maaren P, Narayanan PR, Williams B. Int J Tuberc Lung Dis. 2008 Sep;12(9):1003-8.
• The design effect and cluster samples: optimising tuberculosis prevalence surveys (No. 2 in the Educational series) Williams B, Gopi PG, Borgdorff MW, Yamada N, Dye C. Int J Tuberc Lung Dis. 2008 Oct;12(10):1110-5.
• How to identify tuberculosis cases in a prevalence survey. (No. 3 in the Educational series) van der Werf MJ, Enarson DA, Borgdorff MW. Int J Tuberc Lung Dis.2008 Nov;12(11):1255-60.
• Organisation of a tuberculosis prevalence survey. (No. 4 in the Educational series) van Leth F, Cobelens FG, Onozaki I. Int J Tuberc Lung Dis. 2008 Dec;12(12):1365-9.
• Protecting patients' rights, ensuring safety and quality assurance in tuberculosis prevalence surveys. (No. 5 in the Educational series) Chiang CY, Glaziou P, Enarson DA, Cobelens F, Lew WJ. Int J Tuberc Lung Dis. 2009 Jan;13(1):27-31.
• Inclusion of information on risk factors, socio-economic status and health seeking in a tuberculosis prevalence survey. (No. 6 in the Educational series) Lönnroth K, Holtz TH, Cobelens F, Chua J, van Leth F, Tupasi T, Williams B. Int J Tuberc Lung Dis. 2009 Feb;13(2):171-6.

Other articles/documents

• Measuring tuberculosis burden, trends, and the impact of control programmes. C Dye, A Bassili, AL Bierrenbach, JF Broekmans, VK Chadha, P Glaziou, PG Gopi, M Hosseini, SJ Kim, D Manissero, I Onozaki, HL Rieder, S Scheele, F van Leth, M van der Werf, BG Williams. The Lancet Infectious Diseases, Volume 8, Issue 4, April 2008, Pages 233-243.
• The measurement and estimation of tuberculosis mortality. (No. 5 in the State of the art series) Korenromp, E.L.; Bierrenbach, A.L.; Williams, B.G.; Dye, C. Int J Tuberc Lung Dis. 2009 Mar;13(3):283-303.